Li Long
Welcome,         Profile    Billing    Logout  
 0 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Li, Long
EMBARK, NCT04524390 / 2020-000974-22: Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai

Completed
2
75
Europe, US, RoW
Maralixibat, Formerly LUM001 and SHP625, Placebo
Mirum Pharmaceuticals, Inc.
Biliary Atresia
11/23
02/24
NCT05623943: Comparison of Cerebral Artery Pressure Gradient and Cerebral Blood Flow Measured by Arterial Spin Labeling

Completed
N/A
25
RoW
Endovascular treatment
Xuanwu Hospital, Beijing, National Key Research and Development Project, China
Stroke, Ischemic, Intracranial Atherosclerosis
01/23
02/23
NCT05873348: A Controlled Study on Regulation of Systemic Inflammation by Fecal Bacteria Transplantation in Patients With COVID-19.

Completed
N/A
30
RoW
Fecal microbiota transplantation
Shanghai 10th People's Hospital
Fecal Microbiota Transplantation, COVID-19 Infection
03/23
04/23
NCT05073549: Optimizing Antibiotic Use in Neonatal Intensive Care Units in China

Recruiting
N/A
10000
RoW
Collaborative Antimicrobial Stewardship Program (ASP)
Children's Hospital of Fudan University, China Medical Board
Neonates
09/23
12/23
NCT04920214: Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCC

Recruiting
N/A
500
RoW
SonoVue
Second Affiliated Hospital, School of Medicine, Zhejiang University, Tianjin Third Central Hospital, Sichuan Provincial People's Hospital, Fujian Cancer Hospital, Shandong Jining No.1 People's Hospital, General Hospital of Ningxia Medical University, Beijing Hospital, Red Cross Hospital, Hangzhou, China, Zhejiang Cancer Hospital, Shengjing Hospital
Hepatocellular Carcinoma
12/23
12/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Li, Long
EMBARK, NCT04524390 / 2020-000974-22: Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai

Completed
2
75
Europe, US, RoW
Maralixibat, Formerly LUM001 and SHP625, Placebo
Mirum Pharmaceuticals, Inc.
Biliary Atresia
11/23
02/24
NCT05623943: Comparison of Cerebral Artery Pressure Gradient and Cerebral Blood Flow Measured by Arterial Spin Labeling

Completed
N/A
25
RoW
Endovascular treatment
Xuanwu Hospital, Beijing, National Key Research and Development Project, China
Stroke, Ischemic, Intracranial Atherosclerosis
01/23
02/23
NCT05873348: A Controlled Study on Regulation of Systemic Inflammation by Fecal Bacteria Transplantation in Patients With COVID-19.

Completed
N/A
30
RoW
Fecal microbiota transplantation
Shanghai 10th People's Hospital
Fecal Microbiota Transplantation, COVID-19 Infection
03/23
04/23
NCT05073549: Optimizing Antibiotic Use in Neonatal Intensive Care Units in China

Recruiting
N/A
10000
RoW
Collaborative Antimicrobial Stewardship Program (ASP)
Children's Hospital of Fudan University, China Medical Board
Neonates
09/23
12/23
NCT04920214: Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCC

Recruiting
N/A
500
RoW
SonoVue
Second Affiliated Hospital, School of Medicine, Zhejiang University, Tianjin Third Central Hospital, Sichuan Provincial People's Hospital, Fujian Cancer Hospital, Shandong Jining No.1 People's Hospital, General Hospital of Ningxia Medical University, Beijing Hospital, Red Cross Hospital, Hangzhou, China, Zhejiang Cancer Hospital, Shengjing Hospital
Hepatocellular Carcinoma
12/23
12/23

Download Options